Jump to content

Draft:JCO Precision Oncology

From Wikipedia, the free encyclopedia

This is the current revision of this page, as edited by Liance (talk | contribs) at 17:36, 22 June 2024 (Declining submission: v - Submission is improperly sourced (AFCH)). The present address (URL) is a permanent link to this version.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
JCO Precision Oncology
DisciplineOncology
LanguageEnglish
Edited byJames M. Ford (Stanford Cancer Institute)
Publication details
Publisher
FrequencyMonthly
(2017)
Standard abbreviations
ISO 4JCO Precis. Oncol.
Indexing
ISSN2473-4284
OCLC no.953573973
Links

JCO Precision Oncology (JCO PO) is a peer-reviewed, online-only journal publishing original research, reports, opinions, and reviews that advance the science and practice of precision oncology and define genomics- and other biomarker-driven clinical care of patients with cancer. JCO PO is published by Lippincott, Williams & Wilkins on behalf of the American Society of Clinical Oncology. The editor-in-chief is James M. Ford (Stanford Cancer Institute).

It is indexed in Science Citation Index Expanded (Clarivate), Scopus (Elsevier), Academic Search Ultimate (EBSCO Industries), Embase (Elsevier), and MEDLINE (United States National Library of Medicine).[1]

See also[edit]

References[edit]

  1. ^ "JCO Precision Oncology". MIAR: Information Matrix for the Analysis of Journals.

External links[edit]